Efficacy and Safety of Tralokinumab in Adolescents With Moderate-to- Severe Atopic Dermatitis: Results of the Phase 3 ECZTRA 6 Trial. J of Skin 2022, 6 (2), s29. https://doi.org/10.25251/skin.6.supp.s29.